Nitric Oxide Modulates Metabolic Processes in the Tumor Immune Microenvironment
Authors:
- Christopher L. McGinityCMChristopher L. McGinity
- Erika M. PalmieriErika M. Palmieri
- Veena SomasundaramVSVeena Somasundaram
- Dibyangana D. BhattacharyyaDBDibyangana D. Bhattacharyya
- Lisa A. RidnourLRLisa A. Ridnour
- Robert Y. S. ChengRCRobert Y. S. Cheng
- Aideen E. RyanARAideen E. Ryan
- Sharon A. GlynnSharon A. Glynn
- Douglas D. ThomasDTDouglas D. Thomas
- Katrina M. MirandaKMKatrina M. Miranda
- Stephen K. AndersonSAStephen K. Anderson
- Stephen J. LockettSLStephen J. Lockett
Open Access
- 30 June 2021
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (13) , 7068
Abstract
The metabolic requirements and functions of cancer and normal tissues are vastly different. Due to the rapid growth of cancer cells in the tumor microenvironment, distorted vasculature is commonly observed, which creates harsh environments that require rigorous and constantly evolving cellular adaption. A common hallmark of aggressive and therapeutically resistant tumors is hypoxia and hypoxia-induced stress markers. However, recent studies have identified alterations in a wide spectrum of metabolic pathways that dictate tumor behavior and response to therapy. Accordingly, it is becoming clear that metabolic processes are not uniform throughout the tumor microenvironment. Metabolic processes differ and are cell type specific where various factors promote metabolic heterogeneity within the tumor microenvironment. Furthermore, within the tumor, these metabolically distinct cell types can organize to form cellular neighborhoods that serve to establish a pro-tumor milieu in which distant and spatially distinct cellular neighborhoods can communicate via signaling metabolites from stroma, immune and tumor cells. In this review, we will discuss how biochemical interactions of various metabolic pathways influence cancer and immune microenvironments, as well as associated mechanisms that lead to good or poor clinical outcomes.Keywords
Funding Information
- National Institutes of Health (HHSN261200800001E)
This publication has 127 references indexed in Scilit:
- Serine, glycine and one-carbon units: cancer metabolism in full circleNature Reviews Cancer, 2013
- Reductive carboxylation supports growth in tumour cells with defective mitochondriaNature, 2011
- Nitric oxide and protein phosphatase 2A provide novel therapeutic opportunities in ER-negative breast cancerTrends in Pharmacological Sciences, 2011
- Current Status of the Polyamine Research Field2011
- COX-2 activation is associated with Akt phosphorylation and poor survival in ER-negative, HER2-positive breast cancerBMC Cancer, 2010
- Increased NOS2 predicts poor survival in estrogen receptor–negative breast cancer patientsJournal of Clinical Investigation, 2010
- Dealing with methionine/homocysteine sulfur: cysteine metabolism to taurine and inorganic sulfurJournal of Inherited Metabolic Disease, 2010
- The chemical biology of nitric oxide: Implications in cellular signalingFree Radical Biology and Medicine, 2008
- Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectivesImmunological Reviews, 2008
- Activated K‐RAS increases polyamine uptake in human colon cancer cells through modulation of caveolar endocytosisMolecular Carcinogenesis, 2008